Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess Cardiovascular Outcomes Following Treatment with MK-3102 in Subjects with Type 2 Diabetes Mellitus
To assess the impact of MK-3102 25 mg q.w. on time to confirmed CV outcomes across the MK-3102 program
To assess the safety and tolerability of MK-3102 25 mg q.w.
| Category | Value |
|---|---|
| Study start date | 2012-11-29 |